During the past decade, Knoxville Kidney Center, PLLC conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 12 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 7 clinical trials were completed. i.e. 53.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Knoxville Kidney Center, PLLC" #1 sponsor was "Boehringer Ingelheim" with 4 trials, followed by "Pfizer" with 4 trials sponsored, "Gilead Sciences" with 2 trials sponsored, "Ardelyx" with 1 trials sponsored and "Bayer" with 1 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Knoxville Kidney Center, PLLC" #1 collaborator was "Hospira, now a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Iqvia Pty Ltd" with 1 trials as a collaborator, "Medpace, Inc." with 1 trials as a collaborator and "PPD" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Knoxville Kidney Center, PLLC" are "Chronic Kidney Disease" (4 trials), "Diabetic Kidney Disease" (4 trials), "Chronic Kidney Disease (CKD)" (3 trials), "Chronic Kidney Diseases" (2 trials) and "Diabetic Nephropathies" (2 trials). Many other conditions were trialed in "Knoxville Kidney Center, PLLC" in a lesser frequency.

Most popular intervention types in "Knoxville Kidney Center, PLLC" are "Drug" (21 trials), "Biological" (5 trials), "Other" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "BI 685509" (3 trials), "Epoetin Hospira" (2 trials), "BI 690517" (1 trials) and "Dulaglutide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Knoxville Kidney Center, PLLC" are 24 trials for "All" genders.

Currently, there are NaN active trials in "Knoxville Kidney Center, PLLC". undefined are not yet recruiting, 7 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Knoxville Kidney Center, PLLC, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Knoxville Kidney Center, PLLC, 4 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".